Evidence map›Paper›PMID 38814518›Full record

ArticleHuman cell2024

Tyndallized bacteria prime bronchial epithelial cells to mount an effective innate immune response against infections.

Serena Di Vincenzo, Caterina Di Sano, Claudia D'Anna, Maria Ferraro, Velia Malizia, Andreina Bruno, Marta Cristaldi, Chiara Cipollina, Valentina Lazzara, Paola Pinto and 2 more

Abstract read
In one paragraph

Article in Human cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Serena Di Vincenzo *Institute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Caterina Di Sano *Institute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Claudia D'AnnaInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Maria FerraroInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Velia MaliziaInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Andreina BrunoInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy. andreina.bruno@ift.cnr.it.ORCID http://orcid.org/0000-0002-0510-6336
Marta CristaldiRimed Foundation, 90100, Palermo, Italy.
Chiara CipollinaInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Valentina LazzaraDipartimento di Scienze Economiche, Aziendali E Statistiche-Università Degli Studi Di Palermo, 90100, Palermo, Italy.
Paola PintoDipartimento di Sanità Pubblica, Medicina Sperimentale e Forense-Università di Pavia, 27100, Pavia, Italy.
Stefania La GruttaInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.
Elisabetta PaceInstitute of Translational Pharmacology (IFT), National Research Council (CNR), Via Ugo La Malfa, 90100, Palermo, Italy.

Funding

Consiglio Nazionale delle Ricerche Italian National Research CouncilConsiglio Nazionale delle Ricerche "One Health BasicConsiglio Nazionale delle Ricerche Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases (IN-FACT)
6 · The paper itself

Abstract

Airway epithelium represents a physical barrier against toxic substances and pathogens but also presents pattern recognition receptors on the epithelial cells that detect pathogens leading to molecule release and sending signals that activate both the innate and adaptive immune responses. Thus, impaired airway epithelial function and poor integrity may increase the recurrence of infections. Probiotic use in respiratory diseases as adjuvant of traditional therapy is increasingly widespread. There is growing interest in the use of non-viable heat-killed bacteria, such as tyndallized bacteria (TB), due to safety concerns and to their immunomodulatory properties. This study explores in vitro the effects of a TB blend on the immune activation of airway epithelium. 16HBE bronchial epithelial cells were exposed to different concentrations of TB. Cell viability, TB internalization, TLR2 expression, IL-6, IL-8 and TGF-βl expression/release, E-cadherin expression and wound healing were assessed. We found that TB were tolerated, internalized, increased TLR2, E-cadherin expression, IL-6 release and wound healing but decreased both IL-8 and TGF-βl release. In conclusion, TB activate TLR2 pathway without inducing a relevant pro-inflammatory response and improve barrier function, leading to the concept that TB preserve epithelial homeostasis and could be used as strategy to prevent and to manage respiratory infection, exacerbations included.

Indexed as

BronchiEpithelial CellsImmunity, InnateToll-Like Receptor 2CadherinsCells, CulturedCell SurvivalGene ExpressionHumansInterleukin-6Interleukin-8ProbioticsRespiratory MucosaRespiratory Tract InfectionsCadherinsInterleukin-6Interleukin-8TLR2 protein, humanToll-Like Receptor 2Bronchial epithelial cellsEpithelial homeostasisInnate immune responsesTyndallized bacteria

Identifiers

PMID38814518
PMCPMC11194193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.